Bifidobacterium animalis CP-9
Commercial- Indications
- Gastrointestinal health, Infant nutrition
Company intelligence / Profile preview
Glac Biotech has developed a broad portfolio of clinically validated probiotics and postbiotics for gut, immune, vaginal, oral health, weight management, and more. Their ingredients have received GRAS certification in the US and are supported by human clinical studies demonstrating efficacy across multiple indications. Flagship products have won international awards for microbiome modulation.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Glac Biotech.